NL7812257A - Verbindingen met anticholinergische en antisecretori- sche werking, alsmede farmaceutische preparaten en antitranspiratiepreparaten die zo'n verbinding bevat- ten. - Google Patents

Verbindingen met anticholinergische en antisecretori- sche werking, alsmede farmaceutische preparaten en antitranspiratiepreparaten die zo'n verbinding bevat- ten.

Info

Publication number
NL7812257A
NL7812257A NL7812257A NL7812257A NL7812257A NL 7812257 A NL7812257 A NL 7812257A NL 7812257 A NL7812257 A NL 7812257A NL 7812257 A NL7812257 A NL 7812257A NL 7812257 A NL7812257 A NL 7812257A
Authority
NL
Netherlands
Prior art keywords
antitrapiration
anticholinergic
pharmaceutical
compounds
compound
Prior art date
Application number
NL7812257A
Other languages
English (en)
Original Assignee
Interx Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interx Research Corp filed Critical Interx Research Corp
Publication of NL7812257A publication Critical patent/NL7812257A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/90Benzo [c] furans; Hydrogenated benzo [c] furans with an oxygen atom in position 1 and a nitrogen atom in position 3, or vice versa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
NL7812257A 1977-12-16 1978-12-18 Verbindingen met anticholinergische en antisecretori- sche werking, alsmede farmaceutische preparaten en antitranspiratiepreparaten die zo'n verbinding bevat- ten. NL7812257A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86121077A 1977-12-16 1977-12-16

Publications (1)

Publication Number Publication Date
NL7812257A true NL7812257A (nl) 1979-06-19

Family

ID=25335183

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7812257A NL7812257A (nl) 1977-12-16 1978-12-18 Verbindingen met anticholinergische en antisecretori- sche werking, alsmede farmaceutische preparaten en antitranspiratiepreparaten die zo'n verbinding bevat- ten.

Country Status (15)

Country Link
JP (1) JPS5498711A (nl)
AR (1) AR222478A1 (nl)
AT (1) AT366380B (nl)
AU (1) AU531835B2 (nl)
CA (1) CA1102345A (nl)
DE (1) DE2854308A1 (nl)
DK (1) DK534178A (nl)
ES (1) ES476048A1 (nl)
FR (1) FR2422624A1 (nl)
GB (1) GB2010270B (nl)
IE (1) IE48012B1 (nl)
IT (1) IT1101735B (nl)
NL (1) NL7812257A (nl)
NO (1) NO148776C (nl)
SE (1) SE436027B (nl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045055A1 (de) * 1980-11-29 1982-07-01 Celamerck Gmbh & Co Kg, 6507 Ingelheim Heterocyclische verbindungen
JPS5993075A (ja) * 1982-11-18 1984-05-29 Shionogi & Co Ltd 1−フタリジル−5−フルオロウラシル誘導体の製造法
US5008111A (en) * 1984-10-11 1991-04-16 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
FR2703046B1 (fr) * 1993-03-26 1995-05-05 Poudres & Explosifs Ste Nale Procédé de préparation d'oxalates et d'halogénoglyoxalates alpha- monohalogénés et nouveaux oxalates et halogénoglyoxalates alpha-monohalogénés .
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US5962505A (en) * 1998-08-31 1999-10-05 Bobrove; Arthur M. Method for treating hot flashes in humans
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
AR044134A1 (es) * 2003-05-02 2005-08-24 Novartis Ag Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.
EP1896038B1 (en) 2005-06-03 2016-11-09 Acrux DDS Pty Ltd Method and composition for testosterone transdermal delivery
WO2007077510A2 (en) * 2005-12-30 2007-07-12 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
CN101883556B (zh) 2007-11-02 2013-05-29 艾克若克斯Dds有限公司 激素和类固醇的透皮递送系统
EP2903614B1 (en) * 2012-10-05 2021-09-29 Sphaera Pharma Pte. Ltd Novel compounds, their synthesis and their uses
DE102013013397A1 (de) 2013-08-13 2015-03-12 Epinamics Gmbh Aerosolspender für transdermal wirkende pharmazeutische Zusammensetzungen
CN110041264A (zh) * 2019-04-11 2019-07-23 贺州学院 一种金刚烷基咪唑类离子液体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL101555C (nl) * 1955-03-19
BE798253A (nl) * 1973-04-16 1973-10-16 Bekaert Sa Nv Zitmeubel
US3998815A (en) * 1974-06-24 1976-12-21 Interx Research Corporation 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts

Also Published As

Publication number Publication date
GB2010270A (en) 1979-06-27
ATA901478A (de) 1981-08-15
SE436027B (sv) 1984-11-05
AR222478A1 (es) 1981-05-29
DE2854308A1 (de) 1979-06-21
CA1102345A (en) 1981-06-02
NO148776C (no) 1983-12-14
IE48012B1 (en) 1984-09-05
SE7812911L (sv) 1979-06-17
NO148776B (no) 1983-09-05
AU531835B2 (en) 1983-09-08
GB2010270B (en) 1982-10-20
IT7830735A0 (it) 1978-12-12
AU4264678A (en) 1979-06-21
FR2422624B1 (nl) 1983-10-14
AT366380B (de) 1982-04-13
ES476048A1 (es) 1979-11-01
IE782499L (en) 1979-06-16
IT1101735B (it) 1985-10-07
JPS5498711A (en) 1979-08-03
NO784229L (no) 1979-06-19
FR2422624A1 (fr) 1979-11-09
DK534178A (da) 1979-06-17

Similar Documents

Publication Publication Date Title
NL189196C (nl) 1-fenyl-2-azolyl-4,4-dimethyl-penteen-3-ol derivaten en fungicide-preparaten die zo'n verbinding bevatten.
NL7810520A (nl) Nieuwe 2,6-diaminonebularinen, alsmede farmaceutische preparaten die deze verbindingen bevatten.
ES516504A0 (es) "un compuesto".
NL190664B (nl) Gesubstitueerde benzhydrylpiperidinoderivaten met therapeutische werking en farmaceutische preparaten die deze verbindingen bevatten.
NL191540C (nl) Verbinding met antihypercholesteremische werkzaamheid, alsmede farmaceutisch preparaat dat deze verbinding bevat.
DE3689692D1 (de) "Silicon-resist"-Materialien, die Polysiloxane Verbindungen enthalten.
AU522217B2 (en) Fungicidal 1, 2-dichlorocyanovinyl compounds
NL7812257A (nl) Verbindingen met anticholinergische en antisecretori- sche werking, alsmede farmaceutische preparaten en antitranspiratiepreparaten die zo'n verbinding bevat- ten.
NL191306C (nl) 4-Chinolonderivaat, alsmede geneesmiddel met dit derivaat.
NL188576C (nl) Carbamoyloxazolidonderivaten met pesticide werking alsmede acaricide preparaten, die dergelijke verbindingen bevatten.
NL190848C (nl) 2alfa-cyaan-4alfa,5alfa-epoxy-3-oxo-androstaanverbindingen, alsmede preparaten die deze verbindingen bevatten.
NO883226L (no) Nye aluminium-magnesium-hydroksy-forbindelser.
IT7926662A0 (it) Composizione farmaceutica contenente 3,4-di-idro-3-osso-2-chinossaline.
DK147300C (da) 24,24-difluor-25-hydroxy-6-alkoxy-3,5-cyclovitamin d3 forbindelser
NL7811050A (nl) Nieuwe chinazolinederivaten, werkwijze ter bereiding daarvan alsmede farmaceutische preparaten die zo'n verbinding bevatten.
NL191386C (nl) Een 16-hydroxy-prostaglandine verbinding.
IT1125480B (it) Composto a base di 2,6-diammino-nebularina
IT7821727A0 (it) 3-ammino-1-sostituito-1, 2,4-benzotiadiazin-1-ossido, utile quale agente ipotensivo, eprocedimento per la sua preparazione.
RO77866A (ro) Tablete stabile la depozitare,cu actiune rapida,pentru combaterea vertebratelor care traiesc in cuiburi subterane
TR20170A (tr) Mikrobisitler olarak 1,1 difenileten tuerevleri
IT7920912A0 (it) Dispositivo per l'alimentazione di una miscela da sinterizzazione.
NL930014I2 (nl) 2,4-Dichloor-alpha(N-imidazolylmethyl)-dibenzyletherderivaat, alsmede een deze verbinding omvattend farmaceutisch preparaat.
NL7808946A (nl) Beta-gesubstitueerde diketonen, alsmede preparaten die deze verbindingen bevatten.
NL7804620A (nl) Nieuwe 3,5-dimethyl-piperidine-4-onen en fungicide pre- paraten die deze verbindingen bevatten.
NL7807967A (nl) Nieuwe difenylether derivaten, werkwijze ter bereiding ervan en herbicide preparaten die zo'n verbinding be- vatten.

Legal Events

Date Code Title Description
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.

A85 Still pending on 85-01-01
BV The patent application has lapsed